Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Spoon Guru 🍽️ Transforming Food Choices with AI-powered Nutrition Intelligence 🍏 As a leading provider of personalized nutrition solutions for retailers, Spoon Guru helps increase revenue, customer loyalty, and satisfaction by providing a smarter, more enhanced, and accurate product discovery experience tailored to shoppers' dietary and lifestyle needs. We are revolutionizing the way people experience food and make healthier choices through our cutting-edge Nutrition Intelligence platform. 🔍 Search & Filter 🌿 Recommendations 🔄 Healthier Swaps 📋 Recipe Tagging 🤖 Conversational Commerce (Chatbots) 🚀 Pioneering FoodTech Innovation 🚀 🤝 Partnerships: We are forging partnerships with tech giants and startups alike to integrate our … Type: Startup Activities: healthtech biotech deeptech it services Technologies: A.I. - Machine Learning A.I. | 8 | 2 | 5 | 23 | |
Cumulus Neuroscience Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology Data Analytics | 11 | 0 | 5 | 33 | |
Kanabo Built for Better Health - Get treatment for Pain management and Mental Health here: https://treat-it.clinic - See a GP Online here: https://thegpservice.co.uk - Shop Kanabo here: https://kanabo.store Kanabo Group plc (LSE:KNB) is a digital health company committed to transforming patient care through its innovative technology platform and specialised treatment offerings. Since its inception, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. Leveraging its telehealth capabilities, in 2023, Kanabo launched Treat It, an … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 19 | |
LabGenius Combining human and machine intelligence to accelerate the discovery of uniquely powerful antibodies. LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVATM). Our protein engineering platform integrates several bleeding edge technologies from the fields of machine learning, synthetic biology and robotics. Synthetic Biology, Protein Engineering, Artificial Intelligence, Machine Learning, High Throughput Screening, Medical, Health, DNA Libraries, drug discovery, and protein therapeutics Type: Startup Activities: healthtech deeptech biotech Technologies: A.I. - Machine Learning A.I. Robotics Synthetic Biology | 16 | 1 | 12 | 61 | |
Talking Medicines Revolutionizing Healthcare Marketing with AI-Powered Conversational Intelligence | NY Advertising Week Accelerate 2024 Unlock the AI-Powered Conversational Data Intelligence for Healthcare Marketing Excellence Talking Medicines is transforming Healthcare Marketing by leveraging Advanced Data Science, Curated Large Language Models (LLMs), and Artificial Intelligence. Our mission is to unlock strategic intelligence within Healthcare Professional (HCPs) and Patient Conversational Data, providing actionable intelligence for Healthcare Marketing Agencies. Advanced-Data Science: Utilize cutting-edge data science techniques to analyze vast amounts of HCP and Patient Conversational Data, uncovering unseen intelligence that drive strategic decision-making. Curated Large Language Models: Implement expertly curated LLMs to accurately interpret and … Type: Startup Activities: healthtech biotech deeptech Technologies: A.I. A.I. - Machine Learning A.I. - Natural Language Processing | 6 | 0 | 6 | 42 | |
Abingdon Health plc Improving life by making rapid results accessible to all. Lateral flow test development, manufacture & commercialisation We are lateral flow CDMO experts based in the UK supporting global customers bring their assays to market, from proof of concept, through optimisation and scale up to routine manufacture, along with full-service regulatory consultancy support. Get in touch: email info@abingdonhealth.com today. We believe that by developing the high quality, effective lateral flow rapid tests combined with our manufacturing experience and scale, we can provide the means to accelerate access to rapid testing. This means faster diagnosis and screening in the field, accelerating the … Type: Startup Activities: healthtech biotech deeptech manufacturing Technologies: Synthetic Biology | 7 | 0 | 4 | 73 | |
OME Health The next generation health coaching platform supporting health professionals and enterprise clients. OME Health is a personalised nutrition technology company. Our technology platform enables the use of a broad range of biological and digital health markers to deliver personalised, health outcome-focused nutrition journeys. microbiome, analytics, blood, machine learning, ai, Health coaching, Digital thereapeutics, Digital health, and Behaviour change Type: Startup Activities: healthtech biotech deeptech Technologies: A.I. A.I. - Machine Learning | 3 | 1 | 2 | 3 | |
Lumanity Incisive Thinking, Decisive Action Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, Lumanity transforms data and information into real-world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action. Type: Startup Activities: healthtech biotech deeptech martech constructiontech Technologies: Data Analytics | 7 | 0 | 7 | 955 | |
CuanTec Opening up the potential of the sea Circular Economy company using #innovation and #Technology to create new materials from natural sources. CuanTec have created a novel process, using biology, to extract high quality chitin from fisheries waste of the fisheries, and we use this, the world's 2nd most abundant natural biopolymer to create non-plastic alternatives for products of high consumer demand. Our first product will be packaging from #foodwaste. Preventing pollution and also extending shelf-life of delicate products such as fresh fish. #oceanplastic pollution. #zerowaste and zero tolerance of #marineplastic biopolymer, bioplastics for food packaging, chitosan production through fermentation, Chitosan … Type: Startup Activities: biotech deeptech Technologies: New Materials | 3 | 0 | 0 | 24 | |
Bento Lab We make Bento Lab = a portable PCR workstation for scientists to work in remote places. DNA analysis for anyone, anywhere Our mission is to make DNA lab work accessible to anyone. We create powerful yet easy-to-use devices, affordable supplies, and knowledge guides, to enable beginners and professionals to use the power of PCR anywhere. Genetics, Biotechnology, Bioscience, PCR, Citizen Science, Education, and Field Research | 1 | 0 | 1 | 5 | |
Overwatch Research Leading preclinical research teams use Overwatch to design, track and visualize in vivo studies. Helping solve the reproducibility crisis and focusing on the 3Rs. Experiment Tracking, Preclinical research, Oncology, Xenograft, Animal Welfare, and In Vivo Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 0 | 0 | 0 | 5 | |
Microbiotica Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 2 | 2 | 49 | |
BlockVerify Improving supply chains with blockchain technology. Transparency: Offering transparency among partners to be able to audit and verify transactions Track and Trace: Tracking items through supply chains and recording transfer of ownership and validating locations Diverted Goods and location: Creating the ability to identify items that are diverted and not suitable for a particular location anti-counterfeit, blockchain, verification, and pharmaceutical Type: Startup Activities: biotech deeptech it services Technologies: Blockchain/Cryptocurrency | 3 | 0 | 1 | 5 | |
CN Bio Generate human-specific efficacy and safety data with PhysioMimix® Single- and Multi-organ microphysiological systems. CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals. Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 2 | 7 | 59 | |
Pharmica Making Pharmacy Easy Pharmica is an award-winning online pharmacy in the UK, rated 4.9/5 across more than 190,000 reviews and ranked #1 on Trustpilot in the Online Prescription Medication and Medical Supply Store categories. As a fully regulated pharmacy, we dispense a broad range of MHRA-approved treatments quickly and discreetly from our Central London location and have assisted more than 1.3 million customers and patients thus far. Our patient-centric philosophy and use of cutting-edge technology help us provide a fast, safe, and discreet online pharmacy experience. | 0 | 0 | 0 | 31 | |
Congenica Driving Precision Medicine Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide. Congenica’s Platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care. Our products and services are consolidated … Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics | 10 | 3 | 6 | 48 | |
Mission Therapeutics Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 2 | 6 | 36 | |
Eagle Genomics Networking Microbiome Science Eagle Genomics applies network science to biology. We are revealing the impact of the microbiome on humans, animals and the environment to secure a sustainable future for our food, water, soil and the health of our planet. Our mission is to deliver insight from the microbiome to profoundly change our understanding of wellness and even our fundamental assumptions about life on earth. Our platform transforms scientists’ journey to insights, unifying constellations of complex, multi-dimensional data (the data fabric) to explore and extract signals and networks of relationship, otherwise not detectable by humans alone. This is the frontier … Type: Startup Activities: deeptech it services biotech Technologies: Data Analytics | 29 | 3 | 20 | 31 | |
Fermtech Fermenting change Up-cycling spent grains to make proteins for the food industry. Type: Startup Activities: foodtech biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Antion Biosciences SA Creating breakthrough therapies. Changing lives. Antion Biosciences SA (Antion) is a Swiss biopharmaceutical company developing novel gene and gene-modified cell therapies to treat and cure diseases with significant unmet medical needs. Our proprietary technologies allow for the creation of multimodal treatments that aim to substantially enhance clinical safety and efficacy. We have a number of products in preclinical development, and it is our mission to translate our proprietary technologies into meaningful therapies for the benefit of patients. We are fully committed to creating high-value therapeutic assets, while developing strategies to ensure broad accessibility of our treatments, especially to resource poor … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
Delox Bio-decontamination for everyone, everywhere. Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design of a vast portfolio of compact automatic bio-decontamination equipment. Target applications include laboratory equipment bio-decontamination, hospital rooms, as well as delivering bio-decontamination in biodefense, disaster relief and space sectors. EIC-backed company! Bio-decontamination and Hydrogen-Peroxide Vapor | 0 | 0 | 0 | 7 | |
ProteinLogic Ltd ProteinLogic has developed a novel technology platform (ImmiPrint®) focused on the diagnosis of tuberculosis (TB). Along with HIV/AIDS, TB is the most significant infectious disease worldwide. Early and accurate diagnosis is essential for its control. The ImmiPrint® platform has the potential to deliver an effective blood-based TB diagnostic, and to provide information on disease progression. The test may also be able to predict which individuals are likely to respond to anti-microbial therapy. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
ExCulture Fermentation bioprocess technology Applying a mixed-culture fermentation bioprocess for the production of pharmaceuticals. Biotechnology, Pharmaceuticals, R&D, Fermentation, Glycosaminoglycans, and Heparin | 3 | 0 | 3 | 5 | |
BugBiome Biopesticides from the microbiome At BugBiome, our mission is to create safer pest control solutions by harnessing natural microbiomes. Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials | 2 | 0 | 1 | 7 | |
Infinitopes Preventing deaths from cancer metastases Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 2 | 28 | |
Vandria SA We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases Vandria is a biopharmaceutical company that develops best-in-class small molecule mitophagy inducers to treat age-related and chronic diseases in the fields of Muscle- and CNS diseases with large unmet medical need. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Metrion Biosciences Specialists in ion channel biology Metrion Biosciences is a specialist preclinical drug discovery CRO - your trusted partner for ion channel screening, cardiac safety screening and neuroscience assays. We provide our customers with a range of in vitro screening services, including cardiac safety (GLP hERG, CiPA panel of human cardiac ion channels) and neurotoxicology testing and phenotypic assays on a fee-for-service or collaboration basis. We pride ourselves on being able to provide a flexible and cost effective service with an unparalleled level of expertise. Collectively, we have 250 years experience managing ion channel research programmes. Ion channels, Contract Research (CRO), … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 46 | |
Biohifas We employ the power of mycelium! Biohifas employs the power of mycelium and valorizes industrial side streams into the food. We are developing technology in 3 areas: - Side stream processing into food grade substrates. - Mycelium cultivation in solid state fermentation. - Raw material conservation. We are looking for curious minds, who are amazed by the great kingdom of fungi. Let's employ the power of mycelium and solve the problems that our world faces! fungi, side streams, mycelium, solid state fermentation, side streams, alternative proteins, meat alternatives, circular economy, climate change, industrial by-products, food and beverage, and start up Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 5 | |
Chemify Limited Digitising chemistry and chemical discovery - code to molecules and molecules to code Accelerating molecular discovery through the power of Chemputation. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 92 | |
GenePlanet A leading European provider of innovative healthcare and lifestyle solutions based on preventive genetic testing. GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests. With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 136 | |
AAVantgarde Bio Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 34 | |
Celadon Pharmaceuticals Plc UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannabis-based medicines. Celadon Pharmaceuticals Plc is a UK based pharmaceutical company focused on the research, cultivation, manufacturing, and supply of breakthrough cannabis-based medicines. Founded in 2018 after cannabis was legalised for medicinal purposes, Celadon was one of the first companies to receive Home Office and MHRA licences to cultivate and produce high-THC medicines. In March 2022, Celadon listed on the AIM market of the London Stock Exchange – a huge milestone in the industry and the first since GW Pharma (who were acquired for $7bn by Jazz in 2021). … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 20 | |
Genotic AI-driven IgG antibody design and production AI-driven IgG antibody design and production biotechnology, machine learning, and antibody Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. | 0 | 0 | 0 | 9 | |
lab.bio Updating the standard for open and reproducible computational biology Updating the standard for open and reproducible computational biology | 1 | 1 | 0 | 8 | |
Ionplus AG Scientific Instruments for Radiocarbon Dating and Accelerator Mass Spectrometry Ionplus was incorporated as a spin-off company by the Laboratory of Ion Beam Physics at ETH Zurich. Based on years of research and experience in radiocarbon dating, we develop, build and distribute innovative instruments for radiocarbon sample preparation and measurements. Our products are designed for fast and efficient processing of samples and cover virtually the entire range of dedicated radiocarbon laboratory equipment. | 0 | 0 | 0 | 19 | |
Araris Biotech AG Building tomorrow's antibody-drug conjugates (ADCs) Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering. Antibody Drug Conjugates and ADCs Type: Startup Activities: biotech deeptech Technologies: SaaS | 0 | 0 | 0 | 27 | |
Vitroprobe Analytics Vitroprobe Analytics performs biomolecular analysis at the atomic scale to help design the pharmaceuticals of tomorrow. Vitroprobe Analytics performs biomolecular analysis at the atomic scale to help design the pharmaceutical drugs of tomorrow. The development of new effective pharmaceutical drugs to fight disease is a slow and expensive process. Successful drug design relies on a profound understanding of the interactions between drug candidates and their target molecules in the body. The company has developed a unique platform to analyze target molecular structure in3D with simultaneous identification of individual constituent atoms. With the novel patented technique drug targets can be examined … Type: Startup Activities: deeptech biotech Technologies: Data Analytics | 0 | 0 | 0 | 1 | |
NIMBLE Diagnostics We are developing novel non-invasive technologies to improve the life of millions of patients with implanted stents Stents are one of the most implanted devices in the world, and are used to restore the correct flow of blood or other fluids. They are especially useful to prevent heart attacks or to treat its lasting symptoms, but once implanted can become blocked or damaged, which occur in almost a third of the cases. This progression occurs gradually, but symptoms appear only after the stent is already 90% occluded, which is too late to prevent worsening conditions. Then, in most cases, clinicians … | 4 | 2 | 1 | 16 | |
Grey Wolf Therapeutics First-of-its-kind antigen modulation to address immune dysfunction in oncology and autoimmunity. Next generation therapeutic approach for immuno-oncology & autoimmune diseases. Grey Wolf was founded by leading scientists, drug developers and investors committed to translating the broad therapeutic potential of ERAP-driven antigen modulation into next generation therapies for patients with immunologically-driven diseases. We are a clinical-stage, UK- and Australia-based drug discovery and development company spearheading a new therapeutic strategy based on a first-of-its-kind approach to antigen modulation. Our innovative technology is centered on inhibiting the endoplasmic reticulum aminopeptidases (ERAP1 and ERAP2), which play a central role in the antigen presentation pathway. … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 1 | 39 | |
Healx AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments. Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are more than 10,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to … Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 20 | 3 | 10 | 72 | |
Celtic Renewables Leading the green chemical revolution Celtic Renewables patented technology converts low-value byproducts, residues and waste into high-value green chemicals which directly displace chemicals made from gas and oil in the manufacturing process and lower the carbon footprint of everyday products like skin creams, nail varnish, household cleaning products, paints, medicines and vitamins. Type: Startup Activities: biotech deeptech Technologies: Decarbonization | 7 | 3 | 4 | 54 | |
Levity Crop Science Ltd Improving crop production with pioneering chemistry Levity Crop Science develops sustainable agricultural inputs. Levity's products help farmers produce more and better crops, with less resource, helping move agriculture around the world towards sustainability. Levity branded products are available through distributors. We also help incorporate our technology into third party products for out multinational partners - helping them to produce better products. Levity specialise in nutrient use efficiency (making fertilisers work better and at lower rates), and crop stress tolerance (helping crops grow better when the weather and soil is bad). Fertlilisers, Biostimulants, Biopesticides, and Crop Science Type: Startup Activities: biotech deeptech Technologies: Decarbonization | 1 | 0 | 0 | 9 | |
INFEX Therapeutics Vital new drugs for pandemic infections We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections. Pharmaceuticals, R&D, Antimicrobial Resistance, and Development Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 6 | 1 | 1 | 22 | |
uFraction8 Scalable, efficient bioprocessing uFraction8 builds products around a disruptive new liquid particle processing technology. Following our world leading research, establishing new levels of throughput for massively multiplexed microfluidic devices, our technology will be the key to unlock a prosperous and sustainable future. Our technology offers superior performance and cost savings against the big three liquid processing technologies of filtration, flow centrifugation and flocculation. High volume applications benefit by our unique ability to granularly match targeted volumetric throughputs and our ability to scale this beyond the physical limitations of competing technologies. Maintaining an unobstructed flow path allows our technology to continue … Type: Startup Activities: biotech deeptech Technologies: Decarbonization | 7 | 2 | 5 | 5 | |
Living Pure Natural Organic skincare solutions since 2012 We believe skincare should be effective, natural and cruelty-free. We create every product ourselves· through continuous research, clinical trials and by maintaining the highest standards of quality control, from the first ingredient all the way through to packaging. Living Pure Natural is continuously expanding, proudly serving multiple countries and hundreds of local markets. https://livingpurenatural.com skincare, natural, organic, cruelty-free, awarded, and green Type: Startup Activities: cosmetics biotech Technologies: Bio sourced materials | 0 | 0 | 0 | 5 | |
California Institute for Regenerative Medicine (CIRM) California's Stem Cell Agency The California Institute for Regenerative Medicine (CIRM) is California's stem cell agency. Our mission is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. Stem Cell Research, Regenerative Medicine, Funding Agency, and Clinical Trials | 6 | 0 | 6 | 204 | |
Oregon Bioscience Association Advocate. Cultivate. Educate. Doing all things bio in the Pacific Northwest. Oregon Bioscience Association (@OregonBio) members are involved in cutting edge research and development of innovative health care, agricultural and environmental bio technologies. Our corporate members range from entrepreneurial start ups developing a first product to large multinationals. We also represent the state’s biotech research institutions, service providers to the industry and academic centers of learning. A unified voice for the Oregon bioscience community the Oregon Bio: * Represents the bioscience research to commercialization process * Helps to accelerate the growth of the biosciences industry in all parts of Oregon … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 14 | 0 | 14 | 19 | |
BioTek Instruments BioTek is worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. BioTek, now a part of Agilent Technologies, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. Life Science instrumentation and automation and software. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 181 | |
ATMI ATMI is a global leader in the development of process solutions for the semiconductor and life science industries. Whether it’s a green chemistry used in flash memory manufacturing, game-changing equipment for the safe delivery of toxic ion implant gases, or a revolutionary mixing system for the manufacturing of pharmaceutical compounds, ATMI is leading the way. We combine broad expertise in science and engineering with the latest tools and technologies enabling rapid development and scale-up of new solutions to meet the needs of today’s high-technology marketplace. ATMI promotes a culture that engages employees and fosters growth and development, while offering compensation … Type: SMB Activities: biotech deeptech Technologies: Semiconductors | 0 | 0 | 0 | 48 | |
CALPRO AS, a Svar Life Science company The Calprotectin company Calpro AS was founded by the inventors of the technology behind the ELISA kits for determination of calprotectin in stools and other biological materials. The company is based in Oslo and has the benefit of close professional links with many of the major clinical research departments and medical establishments in Norway, Europe and the USA. Calpro AS provides high quality total solution for Calprotectin analysis. From fully automated system, to home monitoring of patients with IBD. The CalproLabTMELISA kit is validated for testing on faeces, plasma/serum samples, enabling among others assessment of IBD, rheumatic diseases and distinction … Type: SMB Activities: deeptech healthtech biotech | 0 | 0 | 0 | 11 | |
Inceptua Group Pharmaceutical Company & Service Partner Inceptua Group - HelpingPharma. HelpingPatients. Inceptua is a global pharmaceutical services company with market-leading capabilities across multiple business areas. - Inceptua Clinical Trial Supply and Clinical Services provides clinical trial supply, services and logistics, including comparator sourcing of medicines, packaging, labelling, storage, and distribution services. - Inceptua Early Access offers strategic advice, design, facilitation, and implementation of global early access programs, and distributes unlicensed and other medicines worldwide. Inceptua has over 25 years of experience serving life science companies of various sizes, and has global operations with offices across Europe, North America and Asia, including … Type: SMB Activities: deeptech biotech healthtech Technologies: Data Analytics | 2 | 0 | 2 | 115 | |
Aseptix Health Sciences N.V. Aseptix Health Sciences is a global leader in next generation antimicrobials, specializing in novel and patented infection prevention products and technologies for medical, professional and consumer use. Aseptix’ sustainable antimicrobial technologies enable products to safely, effectively and quickly kill contagious pathogens and are used in a wide range of applications, industries and therapeutic areas. The Company markets its products and technologies through a combination of Aseptix branded and third party branded products, and licenses on its portfolio of patented technologies to global industry leaders in their markets. The corporate mission is to become the global alternative for user unsafe and … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Mithra Transforming Women’s Health Through Innovation Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 402 | |
BDD A World Class Drug Delivery Company BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 54 | |
Laboratorios Ojer Pharma [Automatic translation follows] New Technologies for a New Skin Ojer Pharma es una compañía farmacéutica, spin-off de la Universidad de Navarra, que nace al amparo del Centro de Investigación en Farmacobiología Aplicada (CIFA), el Instituto Científico y Tecnológico de Navarra (ICT) y la Fundación Universitaria de Navarra (FUNA) con el objetivo de desarrollar medicamentos y productos dermatológicos innovadores que satisfagan las necesidades de los pacientes a nivel internacional. Ojer Pharma dirige todos sus esfuerzos a investigar y desarrollar productos que aborden las patologías dermatológicas desde una perspectiva global: tratamiento conjunto de causas y síntomas. El objetivo último de la compañía … | 0 | 0 | 0 | 20 | |
BioX Diagnostics Innovations in Veterinary Diagnostics Bio-X Diagnostics brings its 25-year experience and know-how in the veterinary diagnostic field to serve your needs and projects. Our products are carefully designed and manufactured in conformity with various standardized testing protocols (laboratory product range) and to meet market demand for rapid detection (point-of-care product range). What sets us apart is our Flexibility, Curiosity and Perseverance, which we apply on a daily basis to support Veterinarians and Professionals in the Animal Health industry. Veterinary Diagnostics, Biotech, Infectious disease, Farm Animals, IVD, ELISA, PCR, and Point of Care Type: SMB Activities: pettech healthtech deeptech biotech | 5 | 0 | 0 | 29 | |
ANGLE The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. … Type: SMB Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 3 | 1 | 2 | 169 | |
Amarin Corporation Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. For more information, visit www.amarincorp.com. See our Community Guidelines: bit.ly/2L7xEW6 Cardiovascular Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 450 | |
Alimera We See More, TogetherTM Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com . Ophthalmology, Retina, Diabetes, and Pharmaceuticals | 0 | 0 | 0 | 422 | |
Disior We build software to measure and model tissue structures in CT- and MRI-images for better diagnosis and treatment planning. Our solutions are for clinical use. They enable fast, accurate and reproducible measuring for diagnostics and patient-specific, optimized treatment planning. Based on mathematical modelling, Disior algorithms extract the correct shape or structure from the medical image. This way, the software is not dependent on finding familiar structures or comparing something to reference data. We combine engineering and R&D talent with medical and biotechnology professionals. Our team brings together decades of experience in creating world’s best simulation and modelling systems from smartphone … Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. - Image Processing | 8 | 0 | 4 | 19 | |
Nightingale Health Building sustainable healthcare Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample. Nightingale’s Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases. With every sample we help to create a … Type: Startup Activities: healthtech deeptech biotech Technologies: Data Analytics | 12 | 2 | 10 | 117 | |
Sulapac Ltd Accelerating a plastic waste-free future with sustainable, beautiful & functional materials. Like nature. 🌱 Sulapac Ltd is an award-winning material innovation company bringing solutions to the global plastic crisis. By replacing conventional plastic with sustainable, beautiful, and functional Sulapac materials, companies can reduce their carbon footprint, eliminate microplastic pollution, and advance the circular economy. The Helsinki-based company was founded by three scientists in 2016 and serves customers across various industries on three continents. Investors behind Sulapac®, the patented material innovation, include CHANEL and Sky Ocean Ventures. Sulapac has been ranked one of Europe’s 100 hottest startups by WIRED UK in … Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials New Materials | 10 | 5 | 4 | 30 | |
Blueprint Genetics Blueprint Genetics is a genetic diagnostics company focused on inherited diseases. We provide world-class genetic diagnostics and clinical interpretation for hereditary diseases. We are passionate about changing peoples’ lives through development of groundbreaking solutions that take genetic diagnostics from niche to mainstream. Our global team of innovative and motivated people are working at the forefront of genetic knowledge, AI and other areas of life science. Our team consists of more than 20 nationalities working as geneticists, data analysts, laboratory technicians, client service specialists, genetic services consultants, software developers and marketing specialists. Today, we work with customers in over 70 countries … Type: Startup Activities: biotech healthtech deeptech Technologies: A.I. | 3 | 2 | 0 | 245 | |
mjn-neuro Quality of life for people with epilepsy mjn-neuro is a company dedicated to the design, manufacture and commercialization of medical devices with the aim of improving people's quality of life. All this activity is accompanied by an important policy of reinvestment of resources in R&I and social action. The first device that mjn-neuro is developing is mjn-SERAS: an earpiece that assesses the risk of epileptic seizures. The product consists of the earpiece and an app, which are connected to each other via Bluetooth. The earpiece is customised for each user. The main function of the earpiece is to send a … Type: Startup Activities: deeptech biotech manufacturing Technologies: Data Analytics A.I. Wireless | 13 | 2 | 9 | 22 | |
GoodGut Enhancing digestive health GoodGut is a biotechnology company focused on researching and developing analysis systems and therapeutic products to improve the diagnosis and treatment of digestive diseases based on intestinal microbiota. We aim to provide technological tools that will help to obtain a faster, more reliable and lower cost medical diagnosis than existing methods, alongside therapies to improve the quality of life of patients with compromised digestive health. The company was created in 2014 as a spin-off of the University of Girona (UdG) and the Institute of Biomedical Research of Girona Dr. Josep Trueta (IdIBGi). Our facilities can be found … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 1 | 5 | 14 | |
Amadix Early cancer detection in blood AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is extending people's lives, developing disruptive technologies to detect the tumor years in advance, before the symptoms appear. Biotechnology, Cancer Diagnostics, Innovation, Personalized medicine, Blood test, and Biomarkers | 18 | 3 | 13 | 41 | |
Aliri Bioanalysis We deliver data for life > Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions. MALDI Imaging, ADME analysis, Mass Spectrometry Imaging, Preclinical services, Molecular Imaging, Biodistribution, … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 9 | 5 | 4 | 145 | |
Notify Therapeutics Novel treatment paradigm for infertile women. Through targeting of the early and hormone-independent phase of egg maturation, we aim at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
Zymvol Biomodeling Accelerating enzyme discovery and design through computer simulations We are a biotech company that delivers tailor-made enzymes designed to outperform client's needs. At Zymvol we combine cutting edge technology with top scientific expertise to make biocatalysis available to everyone. We are a trusted partner that supports our customers in every stage of their bio-journey: from project definition and prioritization to the development and delivery of tailored enzymes. Our unique approach enables unparalleled accuracy and predictability, along with unprecedented speed. We are the perfect partner for companies aiming to maximize their return on investment and meet their timelines in biocatalysis development. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 4 | 4 | 29 | |
Kimitec Bioinnovation that cares🌱 Kimitec is a biotechnology company applied to agriculture that offers radically innovative natural solutions that are as successful as synthesic chemistry, allowing for a balance between productivity, sustainability, and health preservation. Plant Nutrition, Plant Protection, Biopesticides, Biostimulants, Agriculture, Biotechnology, agricultura, biotecnología, bioestimulantes, biopesticidas, and investigación Type: Startup Activities: agritech biotech deeptech Technologies: Bio sourced materials | 12 | 1 | 8 | 259 | |
Bitac SaaS automatic platform able to code clinical information into standard terminologies such as LOINC, SNOMED or ICD10. BiTAC is a platform of services that combines a team of lifescience specialists trained in Clinical terminologies BiTAC’s main objective is to provide the adoption of standards to guarantee the semantic interoperability in the EHR (Electronic Health Record) and other digital projects. BiTAC provides CTMAP, a SAAS platform with automatic coding modules for clinical terminologies LOINC, SNOMED CT, ICD10, OMIM, ... LOINC (Logical Observation Identifiers Names and Codes), E-health terminological standards implementation, SNOMED CT, ICD9, ICD10, NANDA, NIC, NOC implementation, genomics, biosurveillance, FAIR … Type: Startup Activities: it services biotech healthtech deeptech Technologies: SaaS | 6 | 0 | 0 | 13 | |
DyCare - Digital Rehabilitation Digital Rehabilitation Platform for Hospitals, Insurance Companies and Physiotherapy Clinics DyCare is redefining rehabilitation with ReHub, our advanced digital platform for physiotherapy. Leveraging AI and computer vision, we've empowered over 25,000 patients with personalized, home-based care. Proven in 2M+ exercises, ReHub accelerates recovery and maximizes satisfaction. digital health, machine learning, physical therapy, biofeedback, healthtech, and Physical Therapy Software Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 17 | 3 | 16 | 27 | |
AELIX Therapeutics Developing novel vaccines to cure HIV infection AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 1 | 6 | |
Mesenbio Using mesenchymal stem cells to produce therapeutically meaningful extracellular vesicles. We are a recently incorporated limited company, spun out from the University of York from the Genever lab (www.geneverlab.info), which has over 20 years of experience in cell biology and regenerative medicine. We focus on musculoskeletal regeneration using mesenchymal stem cells (MSCs), with a view to translate our body of work into cutting edge therapeutics. Our current focal point is the field of extracellular vesicles (EVs), which have recently gained substantial traction as a next-generation therapeutic modality. We believe that current approaches have room for improvement in terms of consistency … Type: Startup Activities: healthtech biotech Technologies: Synthetic Biology | 2 | 0 | 2 | 9 | |
Newrotex Ltd UK SME, exploiting the regenerative properties of silk for peripheral nerve repair Newrotex is an Oxford-based SME that has developed an off-the-shelf silk-based conduit for the repair of peripheral nerve injuries. Peripheral Nerve Injury, Silk, Medical Device, Regenerative Medicine, and Biotech Type: Startup Activities: healthtech biotech Technologies: Synthetic Biology | 1 | 0 | 0 | 5 | |
Bioliberty A health tech startup, bridging the gap between hand weakness and independent living. A UK biotech startup company passionate about independent living. Hand weakness affects millions in the UK alone, and we have a solution which will help 🖐️ Type: Startup Activities: biotech deeptech healthtech | 1 | 0 | 1 | 16 | |
Diamante Società Benefit Srl Plant-based Nanotechnologies for autoimmune diseases diagnoses and therapy DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules. The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications. As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has … Type: Startup Activities: biotech deeptech healthtech nanotech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
Nordic microbes THE FUTURE OF AGRICULTURE Nordic microbes is a Danish biotech company based in Odense. We are developing natural, microbial products that can help farmers reduce their use of agrochemicals while maintaining or improving their yield. Our vision is to eliminate the use of pesticides, antibiotics and synthetic fertilisers in agriculture to ensure a sustainable future. We have developed a unique approach and technology platform that enables us to rapidly discover new beneficial microorganisms. Visit our website and youtube chanel to learn more about our technology and our products. https://www.nordicmicrobes.dk https://www.youtube.com/watch?v=GN_BWv9sSPo&t= microbiology, biologicals, microbial discovery, biofertilizer, biopesticides, crop protection, and crop … Type: Startup Activities: biotech Technologies: Bio sourced materials | 2 | 1 | 1 | 26 | |
Made of Genes [Automatic translation follows] Personalized Health for Healthy People 🧬🩸 Personalized Health for Healthy People 💯 Improve your health with your 100% personalized habit change program, 100% tailored to you and what makes you unique 📝 We provide you with rigorous and easily actionable recommendations curated by our team of healthcare professionals, with which you will achieve real results and maximize your health Healthcare, Personalized Medicine, High Performance Computing, Privacy, molecularhealthcare, digitalhealth, personalizedhealth, and healthcaretransformation Type: Startup Activities: biotech healthtech deeptech privacytech it services | 19 | 3 | 12 | 14 | |
Enzymlogic Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery. We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential. The insight … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 2 | 2 | 10 | |
SOM Biotech Biopharmaceutical company focused on the accelerated development of drugs for orphan indications through AI technology SOM Biotech is a biopharmaceutical company focused on the accelerated discovery and development of therapies for orphan indications through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. SOM AI PRO Technology is a proprietary AI-based validated drug discovery technology of SOM Biotech. After defining drug candidates through the technology, we successfully finished the Clinical Phase 2a of two drugs with very positive results. This will contribute to treating two relevant neurodegenerative diseases more effectively, meeting … Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology | 4 | 2 | 3 | 15 | |
BioExpert Network Revolutionise science with your knowledge The BioExpert Network, or BEN, is an exclusive network of experts in the sectors of health, biotechnology, life science and investment. Members have the opportunity to access and evaluate funding proposals for innovative research and development projects before anyone else, and help shape the future of life science and medicine. Proposals which receive the most positive evaluations, in terms of innovation, scientific validity, team and business potential have the opportunity to progress to a crowdfunding campaign with Capital Cell, the first online investment platform in Europe specialized in health and biotechnology. PhD level scientists, physicians, … Type: Incubators & VCs Startup Activities: deeptech healthtech agritech biotech fintech Technologies: Synthetic Biology | 1 | 0 | 1 | 263 | |
Pharmacelera Mine enhanced chemical space. Design superior candidates Quantum-Mechanics and Machine Learning Drug Discovery. Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The methodology mines an unexploited chemical space, finding starting points with larger chemical diversity and improving the creativity of chemists. The technology is based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing (HPC) and it derives from more than 25 years of research. Pharmacelera helps companies in Target Identification, Hit-Identification, Hit-to-Lead and Lead Optimization drug discovery stages by finding novel hits, improving ligand binding properties … Type: Startup Activities: biotech deeptech Technologies: A.I. - Machine Learning A.I. | 1 | 0 | 0 | 26 | |
Qubio NeurocloudR AI-assisted analysis in Neuroimaging At Qubio we develop AI-assisted software for automatic and advanced neuroimaging analysis: Neurocloud, a CE marked tool for quantifying biomarkers in neurodegenerative diseases, which quickly, accurately and effectively helps the doctor (radiologist, neurologist and nuclear medicine doctor with PET, SPECT and MRI imaging) in the diagnosis and follow-up of the patient providing a complete report of the results in a few minutes. Neurocloud stands out for its experience of use and its clinically validated results (CE marked and FDA in progress) that help in the early diagnosis and monitoring of neurological diseases such as Multiple Sclerosis, … Type: Startup Activities: deeptech biotech healthtech it services Technologies: A.I. - Image Processing A.I. A.I. - Deep Learning | 2 | 0 | 2 | 12 | |
Flomics Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification. Flomics is developing novel blood-based diagnostic tools for a broad range of complex diseases. Our proprietary technology accurately identifies pattern changes in the circulating long RNA molecules of patients. With deep learning algorithms we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way. transcriptomics, circulating RNA, liquid biopsies, fluids transcriptomics, artificial intelligence, genome, diagnostics, and genomics Type: Startup Activities: deeptech biotech Technologies: A.I. A.I. - Deep Learning | 4 | 0 | 2 | 26 | |
Nostrum Biodiscovery Rethink and Accelerate Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers. Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering. Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms. With … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 0 | 7 | 41 | |
Agilent Technologies Let’s Bring Great Science to Life. Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s … Type: Large company Activities: biotech deeptech | 19 | 3 | 1 | 17,692 | |
Hackuarium open public science focus, melding bio and tech for fun and continuous education. An open & community-driven lab in the Greater Lausanne area, mixing biology and technology to democratise research, we are a Swiss public service association. You can call us bio-hackerspace, too. Our Mission: Demystify, Inspire, Innovate, using DIT Research and synthetic biology; hacking and making together, encouraging project Open Documentation (also have fun upcycling lab equipment). DIYbio, biohacking, biotech, and biology Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 4 | 2 | 0 | 2 | |
Aquapioneers [Automatic translation follows] Aquapioneers designs, builds and maintains Aquaponic Ecosystems for Urban Farming applications in Barcelona, across food, education and wellbeing. ------------------------------------------------------- Aquapioneers is a Barcelona-based startup that develops sustainable urban agriculture solutions. Our technology is based on the principles of aquaponics: an ancient technique that takes advantage of the interaction of microorganisms, fish and plants in a closed cycle to grow vegetables and fish at the same time. Vision: Aquapioneers applies circular economy values through local sustainable food production, using technological solutions based on aquaponics. Mission: Aquapioneers develops sustainable urban agriculture solutions using aquaponics, an innovative technology that allows … Type: NGO, Think-tanks, Ed, & Culture Activities: smart city agritech biotech deeptech | 3 | 1 | 1 | 2 | |
CPGR Centre for Proteomic and Genomic Research The Centre for Proteomic and Genomic Research (CPGR) plays a pivotal role in advancing South Africa’s ambition to emerge as a leading bio-economy in the 21st century. As a pioneering force in OMICS technology encompassing Genomics, Proteomics, and Bioinformatics, CPGR delivers comprehensive solutions to clients, fostering the growth of the biotechnology sector. Integrating cutting-edge OMICS technologies with bio-computational pipelines, CPGR supports projects in the life sciences and biomedical field in South Africa, all managed through an ISO 9001:2015 certified and compliant quality management system. Founded in 2006 through an initiative by the South African … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 1 | 0 | 1 | 40 | |
PureTech Health Giving Life to Science PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 1 | 8 | 106 | |
AEFI - Asociación Española de Farmacéuticos de la Industria [Automatic translation follows] Non-profit association that brings together professionals from the pharmaceutical industry Established in 1976, the Spanish Association of Industrial Pharmacists is a technical-scientific association that brings together professionals who, from various fields, work in the pharmaceutical industry, institutions or entities linked to the pharmaceutical and healthcare sector (medicines, cosmetics, food, medicinal plants, healthcare products, etc.). Visit our blog 💻 https://www.aefi.org/blog/ Sign up for our training 📚 https://aefi.org/calendario-formaciones/ Pharmacy, Pharmaceutical Industry, Medical Devices, Medical Technology, Regulations, Quality, Training, GxP, EMA, Cosmetics, Veterinary, AEMPS, FENIN, Farmaindustria, Pharmatech, Veterindustria, Galenic, FDA, Registrations, Working Groups, Job Board, Networking, Symposium, Pharmacovigilance, Clinical Research, … Type: SMB Activities: biotech deeptech healthtech Technologies: New Materials | 2 | 0 | 0 | 37 | |
Healthy Cow An ag-tech startup for the better health and welfare of your dairy cows. Healthy Cow is an ag-biotechnology company dedicated to harnessing the power of microbes to develop preventative solutions for common reproductive issues in dairy cows. Developed with a deep understanding of ruminant systems biology, our unique preventative solutions decrease dairy farmers’ reliance on antibiotics and hormones, leading to healthier cows and enabling efficient production of more wholesome and nutritious milk. Our first product is ProPregTM - an intravaginal probiotic gel that is applied before and after calving to re-establish a healthy reproductive microbiome and improve the health of … | 2 | 1 | 1 | 3 | |
PharmEnable Therapeutics Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI-enabled drug discovery platform, chemSEEK, we explore new chemical spaces and discover novel small molecules with antibody-like specificity and selectivity. We are developing a pipeline of wholly owned therapeutics with initial focus on oncology and neurology. We also engage in drug discovery partnerships across a range of disease areas where accessing the target poses a significant challenge. PharmEnable is based in Cambridge, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 1 | 5 | 21 | |
Fraunhofer MEVIS Institute for Digital Medicine Fraunhofer Institute for Digital Medicine MEVIS The mission of Fraunhofer MEVIS is to advance health care by researching and bringing to market solutions for computer-aided medicine, bridging between medical imaging, image-guided therapy, and healthcare informatics. Our focus is to make an impact in clinical routine use. We work closely with clinical and industrial partners to ensure the relevance of our work, to select research topics based on the expected impact on medical care, and to translate our R&D results into viable innovations. We strive to improve accuracy, safety, and efficiency of diagnostic and therapeutic procedures by … Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics A.I. A.I. - Deep Learning A.I. - Image Processing A.I. - Machine Learning | 5 | 2 | 3 | 140 | |
Anavex Life Sciences Anavex utilizes genomic biomarkers in precision medicine to treat severe neurological disorders Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease, a Phase 2 proof-of-concept study in Parkinson's disease dementia, and both a Phase 2 and a Phase 3 study … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 50 | |
Cernostics Providing Deeper Tissue Insights Cernostics has joined Castle Biosciences. Please stay connected! https://www.linkedin.com/company/castle-biosciences-inc-/ Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform … Type: SMB Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 0 | 0 | 0 | 557 | |
Dierks+Company Legal + strategy consultancy for healthcare and life sciences Dierks+Company is a legal + strategy consultancy for healthcare and life sciences. D+C advises clients at the intersection of pharmaceuticals, medical devices, data and diagnostics. D+C provides comprehensive, long-term support for projects, combining legal, medical, strategic, economic, political and operational expertise within our team. We advise organizations that contribute to medical progress and improve people's lives. We do this by: 1. Shape Germany as an outstanding place for research 2. Navigate innovative products and services into market 3. Accelerate the health system transformation Imprint: https://www.dierks.company/imprint/ Innovation, Healthcare and Life Sciences, Strategy, … Type: SMB Activities: legaltech biotech deeptech healthtech Technologies: Data Analytics | 1 | 0 | 1 | 21 | |
Rahko Part of Odyssey Therapeutics Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/ Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 0 | 3 | 1 | |
Corden Pharma - A Full-Service CDMO The partner you need. CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of cGMP facilities across Europe and the US organized under six technology platforms – Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value pharmaceutical products. Visit to learn more > cordenpharma.com Contract Development & Manufacturing Organization (CDMO), Sterile Injectable Drug Products, Aseptic Fill & Finish, Oligonucleotides, Lipid Excipients, LNP Formulation, Peptides, LNP Formulation, Highly … Type: Large company Activities: biotech deeptech manufacturing | 2 | 0 | 2 | 1,526 |